Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0598853 (
forgetting
)
3,232
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Is it true that
hysteria
we see today is no longer that described at the end of the last century? Is it true that Charcot's work on
hysteria
ended in failure? Contrary to currently accepted opinion, it can be demonstrated not only that Charcot truly laid the foundation for the psychological theory of
hysteria
but that his explanation of the mechanism of conversion forms the basis for one of the most effective therapies. Furthermore the major streams of thought in psychopathology have come to complete Charcot's point of view and in no way contradict it. A general view of neurosis can thus be distinguished, while not
forgetting
that these complementary points of view are based on logics of action irreducibles to each other. The interest shown by Charcot in cultural phenomena, such as ecstasy or demoniacal possession, even introduces to an anthropological point of view which situates the hysterical symptom within the more general framework of a universal modality of action.
...
PMID:[Hysteria 100 years later]. 676 90
The rapid increase in numbers of MPD patients in the Anglo-American literature requires discussion of the diagnostic concept. The classification of MPD as Dissociative Disorders by DSM-III-R and ICD-10 follows the traditional conceptualization of
hysteria
and hypnosis. In the view of the majority of modern authors child abuse appears as a new etiological issue. This theme highly sensitive is critically discussed against the background of older psychopathological concepts of
forgetting
. A careful analysis of personality traits and motivation in the individual case help to avoid overuse of the new diagnostic label.
...
PMID:[Multiple personality disorder: old concepts presented as new]. 847 87
Memory and forgetfulness have been viewed since antiquity from perspectives of physical, emotional, and spiritual states of well-being, and conceptualized philosophically. Numerous discussions of memory loss, or case reports, existed, but a fundamental advance in conceptualization of memory loss as a pathological clinical phenomenon originated when Sauvages classified "amnesia" as a medical disorder, in 1763. Originally, amnesia was recognized as a weakening or dissolution of memory, according to a taxonomy that ascribed known causes to the disorder. Etiologic factors included neurological disorders of stroke, hemorrhage, and head injury, metabolic dysregulation, alcohol and substance abuse, toxicity, anoxia, and other acute or chronic (sometimes progressive) brain disorders. Clinical descriptions of amnesia appeared internationally in medical dictionaries and scientific encyclopedias in the early 19th century. The possibility that amnesia could be either idiopathic, or symptomatic of another illness, was proposed based on the wide range of recognized etiologies and associations. Debate ensued regarding the status of amnesia as an illness or a symptom, but regardless, amnesia was soon recognized as an independent disorder of memory, distinguishable from disorders of global intellect, or of consciousness, or of language. Distinctions of amnesia considered its temporal gradient, duration and natural course, nature of onset, severity or depth of memory loss, course, and prognosis. Concepts of retrograde (
forgetting
knowledge preceding onset) and anterograde (difficulty learning, recalling new information) further specified the nature of amnestic memory difficulty. Alcoholic amnesia in Korsakoff's syndrome generated much attention. Amnesia as a clinical feature was critical to the development of notions of dissociation of conscious from subconscious recall in
hysteria
, and differentiation of neurogenically-based from psychogenically-based amnesia became central to understanding post-traumatic states. Amnesia studied as a disorder of memory remains an avenue to enrich clinical understanding of a condition that continues to be powerfully challenging to this day.
...
PMID:Early History of Amnesia. 3122 Aug 49